Pharmacovigilance Risk Assessment Committee (PRAC) – Minutes of PRAC meeting on 13 – 16 January 2025
https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-13-16-january-2025_en.pdf
CTIS newsflash – 25 March 2025
https://www.ema.europa.eu/en/documents/newsletter/ctis-newsflash-25-march-2025_en.pdf
2024 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
https://www.ema.europa.eu/en/documents/report/2024-annual-report-eudravigilance-european-parliament-council-commission_en.pdf
Joint strategy sets direction of EMA and EU medicines regulatory agencies to 2028
https://www.ema.europa.eu/en/news/joint-strategy-sets-direction-ema-eu-medicines-regulatory-agencies-2028
EMA Management Board: highlights of March 2025 meeting
https://www.ema.europa.eu/en/news/ema-management-board-highlights-march-2025-meeting
New clinical trial map launched in the EU
https://www.ema.europa.eu/en/news/new-clinical-trial-map-launched-eu
The ANSM’s involvement in the “Joint Actions” of the “EU for Health” program
https://ansm.sante.fr/page/limplication-de-lansm-dans-les-joint-actions-du-programme-lue-pour-la-sante#:~:text=L’ANSM%20collabore%20%C3%A0%208,au%20sein%20des%207%20autres.&text=Lanc%C3%A9e%20le%201er%20novembre,est%20pilot%C3%A9e%20par%20l’ANSM.
‘European Union for Health’: ANSM involved in 8 joint actions
https://ansm.sante.fr/actualites/union-europeenne-pour-la-sante-lansm-impliquee-dans-8-joint-actions
FAQs: Introduction to the Clinical Trials Regulation (EU) No 536/2014 – CTIS Training Programme – Module 01
https://www.ema.europa.eu/en/documents/other/faqs-introduction-clinical-trials-regulation-eu-no-536-2014-ctis-training-programme-module-01_en.pdf
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 February 2025
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-10-13-february-2025